News

Hawkins, Inc. Prepares for Q1 Fiscal 2026 Financial Results

Hawkins, Inc. Prepares for Q1 Fiscal 2026 Financial Results

Hawkins, Inc. Plans Q1 Fiscal 2026 Financial Results Release

ROSEVILLE, Minn. — Hawkins, Inc. (Nasdaq: HWKN) has announced its forthcoming financial results for the first quarter of fiscal 2026, which ended on June 29, 2025. The expected release is set for July 30, 2025, at around 4:10 p.m. Eastern Time, just after the market closes.

Understanding Hawkins, Inc.

Founded in 1938, Hawkins, Inc. has established itself as a vital player in the water treatment and specialty ingredients sectors. The company excels in formulating, manufacturing, distributing, and blending a diverse array of products tailored to meet the needs of its customers across various industries, including Water Treatment, Food & Health Sciences, and Industrial Solutions.

Extensive Presence and Commitment

Headquartered in Roseville, Minnesota, Hawkins boasts a robust network of 64 facilities throughout 28 states. The company's expansive reach enables it to deliver exceptional customer service and personalized product applications, ensuring that its clients receive the quality they expect. In fiscal 2025, Hawkins, Inc. generated a remarkable revenue of $974 million, supporting a team of approximately 1,100 dedicated employees.

Looking Ahead to Financial Insights

As the date of the financial results approaches, stakeholders and investors eagerly await insights into the company's performance and future outlook. Hawkins, Inc. remains committed to transparency and communication, providing valuable information to the investment community.

Accessing More Information

For those interested in receiving ongoing updates and information regarding Hawkins, Inc., the company encourages visiting their investor relations page. Here, interested parties can learn more about the company’s latest developments and register for email alerts.

Contact Details for Inquiries

For further inquiries, you can reach out to Jeffrey P. Oldenkamp, the Executive Vice President and Chief Financial Officer. He can be contacted at 612/331-6910 for any questions related to financial results or investor relations. Hawkins, Inc. prioritizes clear communication with its investors and stakeholders, ensuring they are well-informed at every step.

Frequently Asked Questions

What is Hawkins, Inc. known for?

Hawkins, Inc. is recognized for its expertise in water treatment and specialty ingredients, offering a variety of solutions tailored to different industries.

When will Hawkins, Inc. release its Q1 fiscal 2026 results?

The company plans to release its Q1 fiscal 2026 financial results on July 30, 2025, after market hours.

How can I stay updated on Hawkins, Inc.?

Interested individuals can visit the investor relations section on Hawkins' website to sign up for email alerts and find the latest news.

Who can I contact for investor inquiries?

Jeffrey P. Oldenkamp, the Executive Vice President and Chief Financial Officer, is the contact person for investor inquiries.

What were Hawkins, Inc.'s revenue figures for fiscal 2025?

Hawkins, Inc. reported an impressive revenue of $974 million in fiscal 2025.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Kenox Pharmaceuticals Revolutionizes Drug Development Landscape

Updated Category News Views 272

Revolutionizing Drug Development Approaches Kenox Pharmaceuticals Inc, a leading name in the development of innovative Orally Inhaled and Nasal Drug Products (OINDPs), has recently announced an exciting extension of its capabilities. The introduction of small scale non-sterile GMP capabilities marks a significant enhancement to its already comprehensive drug development...

Continue Reading
Exciting Listing of AI-themed ATC Coin on CoinW Exchange

Updated Category News Views 211

Exciting Listing of AI-themed ATC Coin on CoinW Exchange CoinW, recognized as a trailblazer in the realm of cryptocurrency trading platforms, is thrilled to announce the listing of ATC, an innovative meme coin designed around artificial intelligence. ATC will be available for trading in both AI, MEME, and SOL Zones. To celebrate this momentous occasion, which marks an...

Continue Reading
Webstar Technology Group’s Innovative Blockchain Venture

Updated Category News Views 370

Revolutionizing Real Estate with Blockchain Tokenization Webstar Technology Group (OTCMKTS: WBSR) is stepping into the future with a bold initiative that harnesses the power of blockchain technology for real estate ventures. This forward-thinking approach not only highlights the company's commitment to innovation but also positions it as a leader in the rapidly evolving...

Continue Reading
Class Action Lawsuits Update: ATYR, MLTX, BAX, JHX

Updated Category News Views 167

Overview of Recent Class Action Lawsuits Several publicly traded companies are facing legal challenges with class action lawsuits initiated on behalf of their shareholders. It's crucial for investors in these companies to be aware of their rights and the deadlines for potential legal actions. This article discusses the companies involved and provides essential information...

Continue Reading
Biodesix Strengthens Partnership with Bio-Rad for Advanced Testing

Updated Category News Views 164

Partnership Expansion Between Biodesix and Bio-Rad Biodesix, Inc. (NYSE: BDSX), a prominent diagnostics solutions company, has recently strengthened its collaboration with Bio-Rad Laboratories. This expanded partnership focuses on developing and validating advanced in vitro diagnostic assays aimed at enhancing the detection of genomic markers in oncology applications....

Continue Reading